Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 106361
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.106361
Figure 2
Figure 2 Survival curves. A: Disease free survival for group immune checkpoint inhibitor (ICI) and group non-ICI (P = 0.043); B: Overall survival for group ICI and group non-ICI (P = 0.816). DFS: Disease-free survival; OS: Overall survival; ICI: Immune checkpoint inhibitor.